Page 39 - 2019年8月第30卷第16期
P. 39
by ELISA. Methyl thymol blue colorimetric method and phosphomolybdic acid method were used to detect the contents of blood
calcium and phosphorus. Correlation of inflammatory factors with related calcium and phosphorus metabolism indexes (blood
calcium,blood phosphorus,PTH)were investigated with Pearson assay. RESULTS:The linear range of astragaloside Ⅳ,emodin
and chrysophanol were 54.537-381.759,2.960-20.720,6.318-44.223 μg/mL,respectively. The limits of quantitation were 0.010,
0.288,0.216 μg/mL;the limits of detection were 0.003,0.096,0.072 μg/mL. RSDs of precision,reproducibility and stability tests
were all lower than 3.0%. The recoveries were 97.18%-102.33%(RSD<3%,n=9). After modeling(before medication),serum
contents of Scr and BUN in model group and administration group were increased significantly,compared with normal group(P<
0.01). After medication,above indexes of administration group were decreased significantly,compared with model group and the
same group before medication(P<0.01). Compared with normal group,the content of blood calcium were decreased significantly,
while the contents of IL-6 and TNF-α were increased significantly(P<0.01). Compared with model group,the content of blood
calcium were increased significantly in JYP medium-dose and high-dose groups,while serum content of PTH in Niaoduqing group,
serum contents of PTH and IL-6 in JYP medium-dose and high-dose groups as well as serum content of TNF-α in administration
group were decreased significantly(P<0.05 or P<0.01). JYP had no significant effect on blood phosphorus in rats,and there was
no correlation of inflammatory factors with related calcium and phosphorus metabolism indexes(P>0.05). CONCLUSIONS:The
established content determination method is simple, specific and sensitive, and can be used for content determination of
astragaloside Ⅳ,emodin and chrysophanol in JYP. JYP can improve renal function of CRF model rats,relieve calcium metabolism
disorder and inhibit the expression of inflammatory factors.
KEYWORDS Jianpi yishen pills;Astragaloside Ⅳ ;Emodin;Chrysophanol;Content determination;HPLC;Chronic renal
failure;Calcium and phosphorus metabolism;Inflammatory factors;Rat
慢性肾衰竭(Chronic renal failure,CRF)是各种慢性 (HPLC),并初步探讨了该方对 CRF 模型大鼠钙磷代谢
肾病(CKD)进行性进展的终末阶段,可造成肾单位受损 和炎症因子等指标的影响,以期为完善 JYP 质量标准、
和肾功能不全,从而诱发以钙磷代谢紊乱,水、电解质、 阐明其治疗CRF的具体机制提供参考。
酸碱平衡异常以及内分泌失调为主要特征的临床综合 1 材料
[1]
征 。2012年流行病学调查结果显示,我国CRF的发病 1.1 仪器
率逐年攀升,已成为危害公众健康的常见严重疾病之 20A 型 HPLC 仪、ELSD-LT Ⅱ型蒸发光散射检测
[2]
一 。目前,临床常用的血液透析、腹膜透析以及化学药 器、SPD-M20A 型二极管阵列(PDA)检测器(日本 Shi-
治疗等方式虽疗效较好,但毒副作用明显,且容易诱发 madzu 公司);Varioskan Flash 型全波长扫描式多功能酶
患者微炎症状态、贫血等并发症,加之治疗费用昂贵,故 标仪、TSU300 型超低温冰箱(美国 Thermo Fisher Scien-
其临床应用受到一定限制 。中医药治疗CRF立足于整 tific公司);BS224S型万分之一电子天平(德国Sartorius
[3]
体观,可调节患者脏腑功能,具有多靶点、多层次、双向 公司);J3000 型动物电子秤(德国 G&G 公司);DD-2 型
调节的综合治疗作用,可有效防止和延缓CRF的发生与 高频电刀(北京东方神健医疗器械有限公司);3K30 型
发展 ,故筛选并开发疗效确切、作用持久且毒副作用小 离心机(德国Sigma公司)。
[4]
的中药制剂对CRF的治疗具有重要意义。 1.2 药品与试剂
健脾益肾丸(Jianpi yishen pills,JYP)是深圳市中医 JYP及其缺黄芪阴性对照样品、缺大黄阴性对照样品
院(以下简称“我院”)经长期临床实践总结并研制的中 (即按处方工艺制备的缺相应药材的对照样品)均由我院
药复方制剂,由黄芪、大黄、山药、丹参、白术、豆蔻、酒苁 制剂室自制,批号分别为20180615、20180625、20180620,
蓉、炙甘草等8味药材组成,具有健脾益肾、通腑泄浊、活 规格均为0.05 g;尿毒清颗粒[阳性对照,康臣药业(内蒙
[5]
血化瘀的功效 。该药治疗 CRF 疗效确切,且无明显不 古)有限责任公司,批号:20130628,规格:每袋5 g];黄芪
[6]
良反应 。前期的初步质量标准研究仅对该方中黄芪、 甲苷对照品(批号:110781-201717,纯度:96.9%)、大黄
甘草、大黄、酒苁蓉等4味药材进行了薄层色谱鉴别,并 素对照品(批号:110756-201512,纯度:98.7%)、大黄酚
参照2015年版《中国药典》(四部)“丸剂”项下相应检查 对照品(批号:110796-201621,纯度:99.2%)均购自中国
项进行了检查 [7-8] ,尚无法满足现代制剂生产和产品检验 食品药品检定研究院;白细胞介素6(IL-6)、肿瘤坏死因
工作的相关要求。为了更好地提高JYP的质量标准,确 子α(TNF-α)、甲状旁腺激素(PTH)酶联免疫吸附测定
保其临床用药的有效性和安全性,本研究在前期质量标 (ELISA)检测试剂盒(天津安诺瑞康生物技术有限公
准的基础上,根据 JYP 的制备工艺,建立了君药黄芪和 司,批号分别为385171104、569171102、468171104);钙、
使 药 大 黄 指 标 成 分 含 量 测 定 的 高 效 液 相 色 谱 法 磷测试盒以及血肌酐(Scr)、尿素氮(BUN)测试盒(南京
·2194 · China Pharmacy 2019 Vol. 30 No. 16 中国药房 2019年第30卷第16期